•  
  •  
 

Date of this Version

9-27-2019

Document Type

Book Chapters

Summary

  • Imaging contrast agents, administered intravenously, are diverse, can be used for diagnostic and therapeutic purposes, and have specific regulatory requirements and development considerations.

  • Collaborative relationships between industry and academia may provide the best approach for the development of these agents.

  • Additional opportunities for development and commercialization include software specific for the analysis of contrast-enhanced examinations.

  • There are special considerations for each class of imaging contrast agents with regards to market growth and potential avenues for future development.

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS